ArborGen proposes public offering

ArborGen Inc., a developer of biotechnology tree seedling products and one of the largest providers of conventional and technology-enhanced seedlings to the global commercial forestry industry, announced recently that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Goldman, Sachs & Co. and Citi will act as joint book-runners for the proposed offering.